The Sakarwadi Manufacturing Facility manufactures bio-based chemicals
The lab facility is also equipped to undertake advanced bio-chemical research for the development of new products as well as optimize manufacturing processes
We believe that it will also foster the government’s vision of ‘Atmanirbhar Bharat’ and ‘Make in India.’
Sakarwadi, Maharashtra, 18 April 2022: Godavari Biorefineries Ltd (“GBL” or the “Company”), a pioneer in manufacturing ethanol-based chemicals in India and one of the largest producers of ethanol in India (source: Frost & Sullivan Report), held a Bhoomi Poojan ceremony for its Sakarwadi Manufacturing Facility at Sakarwadi in Maharashtra. GBL also inaugurated a research laboratory for bio-chemical research and new product development. The Hon’ble Shri Subhash Desai, Cabinet Minister of Industries, Maharashtra, presided at the Bhoomi Poojan while unveiling the research laboratory to augment its pioneering work in biochemical research.
The Sakarwadi Manufacturing Facility manufactures bio-based chemicals that find use in a number of applications, while the research facility is equipped to undertake advanced bio-chemical research fostering the government’s vision of ‘Atmanirbhar Bharat’ and ‘Make in India.’
Speaking on the occasion, Hon’ble Shri Subash Desai, said: “I congratulate Godavari Biorefineries and Mr. Samir Somaiya on this momentous occasion. I’m confident that the journey of betterment of mankind initiated by his forefathers will get a boost with the new R&D center. The Somaiya group is known for its eco-friendly manufacturing units and its contribution to manufacturing green bio-based chemicals. The advancement in research in bio-chemicals and introductions of new green products will propel the Indian chemical industry to become a global manufacturing hub.”
Speaking on the occasion, Shri Samir Somaiya, chairman and managing director, Godavari Biorefineries, said: “We are delighted that the specialty chemicals facility and our ramped up research laboratory will enable us to expand the bio-chemical industry. India has been increasing its exports of chemical products in recent years, and at Godavari Biorefineries our vision is to make green chemicals that reduce the impact on the environment, focus on bio-diversity and the prudent use of scarce resources. There is a growing demand for sustainable and green chemicals all across the world. Our investments in research and development have been instrumental in our growth and are aimed at creating value as well as optimizing resources and processes.”
Godavari Biorefineries Sakarwadi Manufacturing Facility utilizes ethanol and rectified spirits and can use ethanol and rectified spirits manufactured by them to manufacture specialty chemicals including bio-ethyl acetate, MPO, 1,3 butylene glycol, crotonaldehyde and paraldehyde and commodity chemical ethyl acetate. The Company is in the process of expanding its plant to expand their capacity for existing products and introduce additional ethanol based chemicals. We believe that GBL’s new research lab will facilitate development of new products as well as optimizing its manufacturing processes. Godavari Biorefineries has a dedicated team of research scientists who seek to develop new potential marketable products.
We believe that the research lab will also aim to improve manufacturing efficiency on existing products and reduce production costs.
About Godavari Biorefineries
Godavari Biorefineries Limited, established in 1956, is the flagship company of the diversified Somaiya group, which has interests in inter alia, the education, agricultural research, renewable energy and healthcare industries. We utilise sugarcane as a feedstock to manufacture a wide range of products, including sugar, ethanol, bio-based chemicals and power and were among the first few companies in India to utilise sugarcane juice and syrup for the production of ethanol (source: Frost & Sullivan Report). We currently have two manufacturing facilities, one manufacturing facility located in the Bagalkot district in Karnataka (“Sameerwadi Manufacturing Facility”) and another manufacturing facility located in the Ahmednagar district in Maharashtra (“Sakarwadi Manufacturing Facility”).
The molasses from sugarcane is used at the Sameerwadi Manufacturing Facility for the manufacturing of Ethanol. We are one of the largest producers of ethanol in India (source: Frost & Sullivan Report). The chemicals manufactured by us comprise of ethanol-based chemicals such as ethyl acetate, bio-ethyl acetate, MPO, 1,3 butylene glycol, crotonaldehyde, acetaldehyde, acetic acid, bio- acetic acid and paraldehyde- (“Bio-based Chemicals”). The Bio-based Chemicals manufactured by us find application in various industries, including the agrochemical, cosmetics, flavour and fragrance, food, fuel, paints and coatings and pharmaceutical industries, while the ethanol manufactured are sold to oil marketing companies and also find application in the beverages, pharmaceutical and chemical industries.
To learn more about our product portfolio please visit www.godavaribiorefineries.com.
“Godavari Biorefineries Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, to make an initial public offer of its equity shares and has filed a draft red herring prospectus (“DRHP”) with the Securities and Exchange Board of India. The DRHP is available on the website of the SEBI at www.sebi.gov.in as well as on the websites of the book running lead managers, Equirus Capital Private Limited at www.equirus.com, and JM Financial Limited at www.jmfl.com, and the websites of the stock exchange(s) at www.nseindia.com and www.bseindia.com, respectively. Investors should note that investment in equity shares involves a high degree of risk and for details relating to such risk, see "Risk Factors" of the RHP, when available. Potential investors should not rely on the DRHP for any investment decision.
The Equity Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”) or any other applicable law of the United States and, unless so registered, may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. Accordingly, the Equity Shares are being offered and sold outside the United States in offshore transactions as defined in and in compliance with Regulation S and the applicable laws of the jurisdiction where those offers and sales are made. There will be no public offering in the United States.”
